Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome

[1]  C. Garner,et al.  Bassoon Controls Presynaptic Autophagy through Atg5 , 2017, Neuron.

[2]  A. Fejtová,et al.  Bassoon and piccolo regulate ubiquitination and link presynaptic molecular dynamics with activity‐regulated gene expression , 2016, The Journal of physiology.

[3]  Hiroshi Nishimune,et al.  Dual-color STED microscopy reveals a sandwich structure of Bassoon and Piccolo in active zones of adult and aged mice , 2016, Scientific Reports.

[4]  J. Jankovic,et al.  Parkinsonism, movement disorders and genetics in frontotemporal dementia , 2016, Nature Reviews Neurology.

[5]  H. Sasaki,et al.  Frontotemporal dementia and progressive supranuclear palsy‐like syndrome with a novel TARDBP mutation , 2016 .

[6]  W. Tong,et al.  Comparing genetic variants detected in the 1000 genomes project with SNPs determined by the International HapMap Consortium , 2015, Journal of Genetics.

[7]  D. Mann,et al.  Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau , 2015, Acta Neuropathologica.

[8]  M. Frotscher,et al.  Distinct synaptic and neurochemical changes to the granule cell-CA3 projection in Bassoon mutant mice , 2015, Front. Synaptic Neurosci..

[9]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[10]  K. Ohno,et al.  CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study , 2015, The Lancet Neurology.

[11]  E. Tolosa,et al.  The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases , 2014, Movement disorders : official journal of the Movement Disorder Society.

[12]  Janna H. Neltner,et al.  Primary age-related tauopathy (PART): a common pathology associated with human aging , 2014, Acta Neuropathologica.

[13]  Markus S. Schröder,et al.  Bassoon Specifically Controls Presynaptic P/Q-type Ca2+ Channels via RIM-Binding Protein , 2014, Neuron.

[14]  A. Bonnet,et al.  DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypes. , 2014, JAMA neurology.

[15]  Hitoshi Takahashi,et al.  Pathology and sensitivity of current clinical criteria in corticobasal syndrome , 2014, Movement disorders : official journal of the Movement Disorder Society.

[16]  N. Quinn,et al.  “Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide , 2013, Movement disorders : official journal of the Movement Disorder Society.

[17]  L. Wong.  Next generation molecular diagnosis of mitochondrial disorders. , 2013, Mitochondrion.

[18]  C. Garner,et al.  Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation , 2013, The EMBO journal.

[19]  F. Pasquier,et al.  C9orf72 repeat expansions are a rare genetic cause of parkinsonism. , 2013, Brain : a journal of neurology.

[20]  Kerstin Pingel,et al.  50 Years of Image Analysis , 2012 .

[21]  C. van Broeckhoven,et al.  The genetics and neuropathology of frontotemporal lobar degeneration , 2012, Acta Neuropathologica.

[22]  K. Okamoto,et al.  Clinical features of SCA36 , 2012, Neurology.

[23]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[24]  M. Bramerio,et al.  Atypical tauopathy in a patient with LRRK2‐G2019S mutation and tremor‐dominant Parkinsonism , 2012, Neuropathology and applied neurobiology.

[25]  Masahiko Watanabe,et al.  TRIM67 Protein Negatively Regulates Ras Activity through Degradation of 80K-H and Induces Neuritogenesis* , 2012, The Journal of Biological Chemistry.

[26]  Andrew J. Lees,et al.  Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy , 2011, Nature Genetics.

[27]  C. Mariani,et al.  Familial aggregation in Progressive Supranuclear Palsy and Corticobasal Syndrome , 2011, European journal of neurology.

[28]  A. Kakita,et al.  Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity , 2010, Acta Neuropathologica.

[29]  D. Arking,et al.  A GENOME-WIDE LINKAGE AND ASSOCIATION SCAN REVEALS NOVEL LOCI FOR AUTISM , 2009, Nature.

[30]  K. Wakabayashi,et al.  Hippocampal sclerosis with four-repeat tau-positive round inclusions in the dentate gyrus: a new type of four-repeat tauopathy , 2009, Acta Neuropathologica.

[31]  David R Williams,et al.  Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges , 2009, The Lancet Neurology.

[32]  K. Wakabayashi,et al.  Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43 , 2008, Neuroscience Letters.

[33]  H. Sasaki,et al.  Spectrum and prevalence of autosomal dominant spinocerebellar ataxia in Hokkaido, the northern island of Japan: a study of 113 Japanese families , 2007, Journal of Human Genetics.

[34]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[35]  C. Duijn,et al.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.

[36]  Joseph James Duffy,et al.  Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP , 2006, Neurology.

[37]  Nicola Pavese,et al.  Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1 , 2005, Annals of neurology.

[38]  K. Nakayama,et al.  U‐box protein carboxyl terminus of Hsc70‐interacting protein (CHIP) mediates poly‐ubiquitylation preferentially on four‐repeat Tau and is involved in neurodegeneration of tauopathy , 2004, Journal of neurochemistry.

[39]  Y. Takai,et al.  Physical and functional interaction of the active zone proteins, CAST, RIM1, and Bassoon, in neurotransmitter release , 2004, The Journal of cell biology.

[40]  N. Quinn,et al.  Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP , 2003, Neurology.

[41]  Douglas Walker,et al.  Hippocampal Sclerosis Dementia with Tauopathy , 2003, Brain pathology.

[42]  T. Ohm,et al.  Cholesterol storage and tau pathology in Niemann–Pick type C disease in the brain , 2003, The Journal of pathology.

[43]  A. C. Meyer,et al.  Functional Inactivation of a Fraction of Excitatory Synapses in Mice Deficient for the Active Zone Protein Bassoon , 2003, Neuron.

[44]  A. Delacourte,et al.  Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms , 2002, Acta Neuropathologica.

[45]  N. Shibata,et al.  Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy , 1998, Acta Neuropathologica.

[46]  I Litvan,et al.  Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders , 1996, Journal of neuropathology and experimental neurology.

[47]  J. Trojanowski,et al.  Mutations in COQ2 in familial and sporadic multiple-system atrophy. , 2013, The New England journal of medicine.

[48]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.